Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response — which in severe cases can be life-threatening. A team of researchers has now identified a promising bioactive compound that could effectively reduce symptoms and slash fatality risk. The compound blocks a receptor on certain defense cells, thus preventing a derailed immune response.
Quelle: ScienceDaily | Allergy
Titelbild/Grafik: ScienceDaily News
Kommentare und Fragen
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von ScienceDaily | Allergy
- New bioactive compound for difficult-to-treat allergies
- Recently discovered immune cell type is key to understanding food allergies
- Researchers find intestinal immune cell prevents food allergies
- Surgery doesn't always help with chronic rhinosinusitis -- a new risk score predicts treatment efficacy
- Eating gradually increasing doses of peanut butter enables children with high-threshold allergy to safely consume peanuts, study suggests
- Molecular basis of food allergy
- Why you shouldn't scratch an itchy rash: New study explains
- New clues to the mechanism behind food tolerance and allergies
- Discovery of genetic loci associated with allergic sensitization
- A common antihistamine shows promise in treating liver complications of a rare disease complication
